Orna Therapeutics
Orna Therapeutics is a biotechnology company focused on designing and delivering fully engineered circular RNA (oRNA) therapeutics. Its platform combines engineered circular RNA constructs that drive protein expression with delivery solutions, notably lipid nanoparticles, to enable safe and effective in vivo therapies. The approach expands therapeutic possibilities across diseases such as oncology, autoimmune diseases, and infectious diseases. Established in 2019 and based in Cambridge, Massachusetts, Orna Therapeutics pursues therapies built on oRNA constructs designed to express therapeutic proteins in a controlled manner.
Top Stages
1 past transactions
ReNAgade Therapeutics
Acquisition in 2024
ReNAgade Therapeutics specializes in RNA therapeutics, focusing on its vast potential to treat diseases. The company's comprehensive RNA platform enables coding, editing, and gene insertion using an all-RNA system for developing new medications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.